ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

TARA Protara Therapeutics Inc

2,91
0,00 (0,00%)
06 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Protara Therapeutics Inc TARA NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 2,91 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
2,91
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.5.202414:00GLOBEProtara Therapeutics Announces First Quarter 2024 Financial..
05.4.202414:04GLOBEProtara Therapeutics Announces Oversubscribed $45 Million..
05.4.202414:02GLOBEProtara Therapeutics Announces Alignment with FDA on..
05.4.202414:00GLOBEProtara Therapeutics Announces Positive Three-Month Data..
13.3.202413:00GLOBEProtara Therapeutics Announces Fourth Quarter and Full Year..
28.2.202414:00GLOBEProtara Therapeutics to Present at the TD Cowen 44th Annual..
23.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.11.202314:30GLOBEProtara Therapeutics Announces Presentation of Additional..
15.11.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
03.11.202313:31EDGAR2Form S-3 - Registration statement under Securities Act of..
03.11.202313:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.11.202313:10EDGAR2Form 8-K - Current report
03.11.202313:00GLOBEProtara Therapeutics Announces Third Quarter 2023 Financial..
23.10.202314:00GLOBEProtara Therapeutics Announces Dosing of First Patient in..
20.9.202314:30GLOBEProtara Therapeutics Announces Dosing of First Patient in..
05.9.202313:30GLOBEProtara Therapeutics to Present at the H.C. Wainwright 25th..
03.8.202314:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.8.202314:12EDGAR2Form 8-K - Current report
03.8.202314:00GLOBEProtara Therapeutics Announces Second Quarter 2023 Financial..
18.7.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.7.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.5.202314:00GLOBEProtara Therapeutics Announces Dosing of First Patients in..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock